Domain Partners — Full Portfolio
6 tracked investments · listed companies and verified rows first
aTyr is a clinical-stage biotechnology company developing therapies derived from tRNA synthetase biology to treat fibrosis and inflammation, with its lead candidate efzofitimod in clinical trials for interstitial lung disease.
BiotechHealthtechMedical DevicesSan Diego, US
Amir Nashat(Non-Management Director)Paul Schimmel(Non-Management Director)Akkaraju Srinivas(Non-Management Director)John D. Mendlein(Executive Officer, Director)David Weiner(Executive Officer)Ed Penhoet(Non-Management Director)
Board seatJames C. Blair· per SEC Form D · $76.3M raise · filed Apr 2015
BiotechBoston, US
SARKIS K. MAZMANIAN(Director)JAMES C. BLAIR(Director)Ronald C. Renaud Jr.(Director)DAVID H. DONABEDIAN(CHIEF EXECUTIVE OFFICER OF THE ISSUER)MICHELLE DIPP(Director)Henry Wolf(Director)
Board seatJames C. Blair· per SEC Form D · $19.1M raise · filed Jun 2017
ChromaCode develops a High-Definition PCR (HDPCR) multiplexing platform that enables genomic solutions for oncology and precision medicine, offering faster results and cost-effective workflows through automated interpretation and cloud-based software.
AI & Machine LearningBiotechHealthtechMedical DevicesCarlsbad, US
Aditya Rajagopal(Director)Paul Flook(Executive Officer, Director)James C. Blair(Director)Gregory J. Gosch(Executive Officer, Director)Axel Scherer(Director)Alexander G. Dickinson(Director)
Board seatJames C. Blair· per SEC Form D · $12.1M raise · filed Apr 2017
HealthtechSanta Clara, US
Hanson Gifford III(Director)Henry Plain, Jr.(Director)R. Michael Kleine(Executive Officer, Director)Nimesh Shah(Director)Stacy Seltzer(Director)Brigid Makes(Executive Officer)
Board seatBrian H. Dovey· per SEC Form D · $33.6M raise · filed Jun 2016
BiotechLa Jolla, US
Preston Klassen(Executive Officer)Joseph Hagan(Executive Officer)Brian H. Dovey(Director)Louis C Bock(Director)Patrick J Mahaffy(Director)Lota S Zoth(Director)
Board seatBrian H. Dovey· per SEC Form D · $49.6M raise · filed Mar 2017
Lake Forest, US
John T. Kilcoyne(Executive Officer, Director)Renee Ryan(Director)Gilbert H. Kliman(Director)Andy Corley(Director)Inna Martin Eitan(Director)Louis Bunn(Executive Officer)
Board seatBrian H. Dovey· per SEC Form D · $45M raise · filed Nov 2016
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.